It was a pleasure to welcome Mochida Pharmaceutical Co. Ltd board member Mr. Chu Sakata-san to the PBC Biomed headquarters in Shannon last week and to show him around our newly expanded facility.
Alongside its core pharmaceutical and healthcare operations, Mochida is actively growing its #biomaterials business, establishing it as a key driver of the company’s future growth.
A major area of focus in this expansion is the development of #alginate-based projects, leveraging the material’s strong potential in medical and biotechnological applications. ReFeel® Nerve Repair Solution represents the first U.S. launch from Mochida Pharmaceuticals Ltd.’s new Biomaterials Division.
PBC Biomed is proud to partner with Mochida on the development and commercialisation of ReFeel®, as well as their growing alginate technology pipeline. We look forward to continued partnership in 2026.
#Acceleratingmedicalinnovation#PBCBiomed#MochidaPharmaceuticalsLtd #Partners

Welcome Mochida Pharmaceutical
Search News Items
Categories
- Awards (11)
- Biomaterials (24)
- Biovet (13)
- Bone Adhesive (20)
- Bone Disease Solution (4)
- Bone Healing (14)
- Certification (1)
- Client (2)
- Collaboration (30)
- Conferences (24)
- Contract Manufacturing (3)
- Day One Trauma Charity (4)
- Development (21)
- Events (65)
- Government Funding (3)
- Lectures (7)
- Medical Devices (9)
- Medical Implants (6)
- Memphis Office (8)
- New Hire (11)
- On TV/Radio (2)
- Partnership (6)
- Press Release (8)
- Publications (7)
- ReFeelNerveRepairSolution (12)
- Regenerative Medicine (15)
- Relationship-building (18)
- Research (18)
- Sports & Social (3)
- Sports Partners (9)
- Student Placements (3)
- Uncategorized (6)
- Upcoming Events (6)
- US Office (6)

